Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DENR pseudogene 2 (DENRP2) is a pseudogene derived from the DENR (density-regulated re-initiation and release factor) gene. Pseudogenes are genomic sequences that resemble functional genes but are generally nonfunctional due to accumulated mutations that disrupt their coding potential or regulatory elements[4]. They are classified into several types, with DENRP2 likely being a processed pseudogene, meaning it arose from reverse transcription and genomic integration of an mRNA transcript, typically lacking introns and often regulatory sequences[4]. As a pseudogene, DENRP2 is not considered a direct therapeutic target, nor is it currently associated with specific biological functions, disease roles, or drug interactions. Pseudogenes like DENRP2 may still play roles in gene regulation, for example by acting as microRNA decoys, but such functions remain speculative for this specific pseudogene in the absence of direct evidence. Structural and functional details specific to DENRP2 are not well characterized in the available literature, and it is primarily annotated as a pseudogene with no known protein product[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DENR pseudogene 2 (DENRP2) (DENRP2).